Ophthalmic composition for reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension, comprises netarsudil or its salts; bimatoprost or its salts and one or more excipients
	KUMAR A; UPADHYAY S C; HASIJA R
	2023-08-31
专利权人	MANKIND PHARMA LTD (MANK-Non-standard)
申请日期	2023-08-31
专利号	IN202311058327-A
成果简介	NOVELTY - Ophthalmic composition comprises netarsudil or its salts; bimatoprost or its salts and one or more excipients. USE - Ophthalmic composition for reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; for lowering intraocular pressure in a patient suffering from elevated intraocular pressure. No biological data given. ADVANTAGE - The composition is free of phosphate buffer; provides less side effects, better/comparable bioavailability and better stability when compared to the marketed formulation; shows synergistic effect as compared to the effects shown by the individual formulations; is sterile, free form particles and especially prepared for instillation into the eye; reduces the side effect of benzalkonium chloride used in netarsudil and bimatoprost ophthalmic composition.
IPC 分类号	A61K-031/165 ; A61K-047/02 ; A61K-047/12 ; A61K-047/18 ; A61K-047/26 ; A61K-047/44 ; A61K-009/00 ; A61K-009/08
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/20589
专题	中国科学院新疆生态与地理研究所
作者单位	MANKIND PHARMA LTD (MANK-Non-standard)
推荐引用方式 GB/T 7714	KUMAR A,UPADHYAY S C,HASIJA R. Ophthalmic composition for reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension, comprises netarsudil or its salts; bimatoprost or its salts and one or more excipients. IN202311058327-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。